
Currently out of the existing stock ratings of James Quigley, 29 are a HOLD (54.72%), 21 are a BUY (39.62%), 3 are a SELL (5.66%).
Analyst James Quigley, currently employed at MORGAN STANLEY, has had 45.56% of price targets met with an average potential upside of 13.65%, reached in 151 days on average. Previously, James Quigley worked at JPMORGAN, BERENBERG.
James Quigley has documented 100 price targets and ratings displayed on 9 stocks. The coverage is on Healthcare, Consumer Defensive sectors.
Most recent stock forecast was given on KYMR, Kymera Therapeutics at 27-Oct-2026.
Analyst best performing recommendations are on KYMR (KYMERA THERAPEUTICS).
The best stock recommendation documented was for GLPG (GALAPAGOS NV ADR) on 1/4/2022. The price target of $67 was fulfilled within 24 days with a profit of $12.77 (23.55%), with a performance score of 9.81.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Hold Since 06-Feb-2024
$17
2 years 9 months 15 days ago
(06-Feb-2024)
3/4 (75%)
$12.45 (273.63%)
250
Buy Since 16-Jun-2023
$17
$17
2 years 9 months 16 days ago
(05-Feb-2024)
3/3 (100%)
$-0.27 (-1.56%)
96
Buy Since 16-Jan-2024
2 years 10 months 2 days ago
(19-Jan-2024)
4/7 (57.14%)
$2.7 (41.54%)
490
Buy Since 05-Dec-2023
$8.5
$10
2 years 11 months 16 days ago
(05-Dec-2023)
2/3 (66.67%)
$0.92 (12.14%)
106
Buy Since 05-Dec-2023
$8.5
$10
2 years 11 months 16 days ago
(05-Dec-2023)
3/4 (75%)
$0.92 (12.14%)
253
Which stock is James Quigley most bullish on?
Which stock is James Quigley most reserved on?
What Year was the first public recommendation made by James Quigley?